Schreiner MediPharm and Sterinova have developed Needle-Trap Secu, a new needle protection label that not only increases safety, but also reduces waste and saves space. The new product combines efficiency and environmental awareness for the healthcare industry.
Schreiner MediPharm has introduced Needle-Trap Secu, a new product developed in collaboration with Sterinova, a Canadian subsidiary of the medical technology company B. Braun. This new Needle protection label with integrated sealing function is designed to improve sustainability and cost efficiency in the storage, transport and disposal of prefilled syringes.
Sterinova, which specialises in ready-to-use injectable drugs, has been using Schreiner MediPharm's tried-and-tested Needle-Trap system for its ready-to-use heparin syringes since 2016. This system protects against needlestick injuries and saves space and resources thanks to its compact design. The combination of Needle-Trap, in which the Needle catcher integrated directly into the label enables simple application in everyday medical practice and contains Less plastic than conventional needle protection systems.
The new variant, Needle-Trap Secu, offers an integrated first-opening indication: a special Sealing tab ensures the integrity of the prefilled syringe until use. When the syringe cap is removed, the seal is triggered and irreversibly indicates the first opening. This integrated sealing function makes a No need for additional blister packaging, This leads to considerable space savings and a reduction in waste and costs. Security elements also prevent the seal from being reused unnoticed.
Pierre Beaulieu, Vice President Sales and Marketing at Sterinova, explained that the company has relied on Needle-Trap for almost ten years because it perfectly combines needle protection and sustainability. The new Needle-Trap Secu solution reinforces these positive properties and makes it possible to offer pre-filled heparin syringes loose in a pack, as the Integrity of each individual syringe protected by the safety seal be.
Hospitals also benefit from this multifunctional solution, as additional blister packaging is no longer required, which leads to a significant reduction in waste. According to Beaulieu, waste can be reduced by 46 per cent compared to conventional blister packaging. In addition, the compact needle trap solution contributes to lower CO2-emissions, as waste is reduced at source. This approach has a positive impact on the entire supply chain, from the point of manufacture to waste disposal in hospitals. The labelled integrated needle trap also consists of up to 50 per cent recycled pellets, which further reduces the ecological footprint.
With the introduction of Needle-Trap Secu, Schreiner MediPharm is taking a further step towards greater sustainability and efficiency in the healthcare sector, which benefits medical staff and patients as well as the environment.
Source: Schreiner Group
